Biofrontera AG - Company Profile
Powered by 
All the sales intelligence you need on Biofrontera AG in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Biofrontera AG fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Biofrontera AG.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Biofrontera AG (Biofrontera), a biopharmaceutical company that develops, sells, and distributes dermatological drugs and medical cosmetics for the care, protection, and treatment of skin diseases. Its lead product Ameluz, strategic alliances and partnerships, and focused R&D activities are its strengths, even as geographical concentration could be a major cause for concern for the company. Biofrontera could benefit from strategic agreements, innovation in nanoemulsion technology, and the growing incidence of psoriasis. However, uncertain R&D outcomes, high competition, and reliance on third-party payors could affect the company's growth prospects.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer